// App-Quantinova.ai

238 : Androgen insensitivity syndrome germline loss-of-function mutations in the androgen receptor that acquire somatic gain-of-function in prostate cancer

Researchers

Presenter

  • Philip A. Watson

Principal Investigators

  • Minna D. Balbas

  • Zeda Zhang

  • Taslima F. Ishmael

  • Kayla E. Lawrence

  • John Wongvipat

  • Sophie D. Sawyers

  • Yi-Mi Wu

  • Dan Robinson

  • Yang Shen

  • Arul M. Chinnaiyan

  • Charles L. Sawyers

Medical Centers

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • University of Michigan School of Public Health, Ann Arbor, MI

  • Texas A&M University, College Station, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

  • Androgen insensitivity syndrome

  • Prostate cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Dihydrotestosterone

  • Enzalutamide

  • Bicalutamide

  • Androgen Tear

  • folitixorin calcium

  • ARN-509

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved